Cargando…
Companion Tumor Sequencing to Assess the Clinical Significance of Germline Sequencing in Children With Cancer
This case-control study assesses the clinical significance of germline sequencing in children with cancer.
Autores principales: | Mutetwa, Tinaye, Goudie, Catherine, Foulkes, William D., Polak, Paz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603075/ https://www.ncbi.nlm.nih.gov/pubmed/34792595 http://dx.doi.org/10.1001/jamanetworkopen.2021.35135 |
Ejemplares similares
-
Clinically significant germline pathogenic variants are missed by tumor genomic sequencing
por: Stout, Leigh Anne, et al.
Publicado: (2023) -
RAD51C germline mutations in breast and ovarian cancer patients
por: Akbari, Mohammad R, et al.
Publicado: (2010) -
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
por: Pertesi, Maroulio, et al.
Publicado: (2019) -
Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing
por: Terraf, P., et al.
Publicado: (2022) -
Family-based germline sequencing in children with cancer
por: Kuhlen, Michaela, et al.
Publicado: (2018)